161 related articles for article (PubMed ID: 9683302)
1. A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group.
Masuda N; Fukuoka M; Fujita A; Kurita Y; Tsuchiya S; Nagao K; Negoro S; Nishikawa H; Katakami N; Nakagawa K; Niitani H
Br J Cancer; 1998 Jul; 78(2):251-6. PubMed ID: 9683302
[TBL] [Abstract][Full Text] [Related]
2. Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.
Jagasia MH; Langer CJ; Johnson DH; Yunus F; Rodgers JS; Schlabach LL; Cohen AG; Shyr Y; Carbone DP; Devore RF
Clin Cancer Res; 2001 Jan; 7(1):68-73. PubMed ID: 11205920
[TBL] [Abstract][Full Text] [Related]
3. Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer.
Negoro S; Masuda N; Takada Y; Sugiura T; Kudoh S; Katakami N; Ariyoshi Y; Ohashi Y; Niitani H; Fukuoka M;
Br J Cancer; 2003 Feb; 88(3):335-41. PubMed ID: 12569373
[TBL] [Abstract][Full Text] [Related]
4. Three-week schedule of irinotecan and cisplatin in advanced non-small cell lung cancer: a multicentre phase II study.
Cardenal F; Domine M; Massutí B; Carrato A; Felip E; Garrido P; Juan O; Artal A; Barneto I; López-Vivanco G; Balcells M; Rosell R
Lung Cancer; 2003 Feb; 39(2):201-7. PubMed ID: 12581574
[TBL] [Abstract][Full Text] [Related]
5. Triple combination chemotherapy with cisplatin, docetaxel, and irinotecan for advanced non-small cell lung cancer: a phase I/II trial.
Kiura K; Takigawa N; Segawa Y; Tabata M; Shibayama T; Gemba K; Bessho A; Fujimoto N; Takata I; Hotta K; Fujiwara K; Tokuda Y; Kuyama S; Shinkai T; Ueoka H; Tanimoto M;
J Thorac Oncol; 2007 Jan; 2(1):44-50. PubMed ID: 17410009
[TBL] [Abstract][Full Text] [Related]
6. Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer.
Shinkai T; Arioka H; Kunikane H; Eguchi K; Sasaki Y; Tamura T; Ohe Y; Oshita F; Nishio M; Karato A
Cancer Res; 1994 May; 54(10):2636-42. PubMed ID: 8168091
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer.
DeVore RF; Johnson DH; Crawford J; Garst J; Dimery IW; Eckardt J; Eckhardt SG; Elfring GL; Schaaf LJ; Hanover CK; Miller LL
J Clin Oncol; 1999 Sep; 17(9):2710-20. PubMed ID: 10561345
[TBL] [Abstract][Full Text] [Related]
8. Dose-finding study of irinotecan and cisplatin plus concurrent radiotherapy for unresectable stage III non-small-cell lung cancer [seecomments].
Yokoyama A; Kurita Y; Saijo N; Tamura T; Noda K; Shimokata K; Matsuda T
Br J Cancer; 1998 Jul; 78(2):257-62. PubMed ID: 9683303
[TBL] [Abstract][Full Text] [Related]
9. Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study.
Ueoka H; Tabata M; Kiura K; Shibayama T; Gemba K; Segawa Y; Chikamori K; Yonei T; Hiraki S; Harada M
Br J Cancer; 1999 Feb; 79(5-6):984-90. PubMed ID: 10070901
[TBL] [Abstract][Full Text] [Related]
10. Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group.
Ueoka H; Tanimoto M; Kiura K; Tabata M; Takigawa N; Segawa Y; Takata I; Eguchi K; Okimoto N; Harita S; Kamei H; Shibayama T; Watanabe Y; Hiraki S; Harada M
Br J Cancer; 2001 Jul; 85(1):9-13. PubMed ID: 11437395
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of 3-week scheduling of irinotecan in combination with cisplatin in patients with advanced nonsmall-cell lung cancer.
Saito H; Kudoh S; Nakagawa K; Negoro S; Matsui K; Semba H; Takada M
Am J Clin Oncol; 2006 Oct; 29(5):503-7. PubMed ID: 17023787
[TBL] [Abstract][Full Text] [Related]
12. Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer.
Socinski MA; Sandler AB; Miller LL; Locker PK; Hanover CK; Elfring GL; Israel VK; Pirotta N; Natale RB
J Clin Oncol; 2001 Feb; 19(4):1078-87. PubMed ID: 11181672
[TBL] [Abstract][Full Text] [Related]
13. [A phase II study of irinotecan combined with cisplatin in non-small cell lung cancer. CPT-11 Lung Cancer Study Group].
Nagao K; Fukuoka M; Fujita A; Kurita Y; Saito R; Niitani H; Negoro S; Katakami N; Nakano M
Gan To Kagaku Ryoho; 2000 Mar; 27(3):413-21. PubMed ID: 10740635
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancer.
Kakolyris S; Kouroussis C; Souglakos J; Agelaki S; Kalbakis K; Vardakis N; Vamvakas L; Georgoulias V
Lung Cancer; 2001 Dec; 34 Suppl 4():S71-6. PubMed ID: 11742707
[TBL] [Abstract][Full Text] [Related]
15. Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin.
Kakolyris S; Kouroussis C; Kalbakis K; Mavroudis D; Souglakos J; Nvardakis ; Kremos S; Georgoulias V
Ann Oncol; 2000 Jun; 11(6):757-60. PubMed ID: 10942068
[TBL] [Abstract][Full Text] [Related]
16. Establishment of the standard regimen for non-small-cell lung cancer in Japan.
Masuda N
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):13-8. PubMed ID: 11221016
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in unresectable and locally advanced non-small cell lung cancer.
Oka M; Fukuda M; Fukuda M; Kinoshita A; Kuba M; Ichiki M; Rikimaru T; Soda H; Takatani H; Narasaki F; Nagashima S; Nakamura Y; Hayashi N; Kohno S
Eur J Cancer; 2001 Jul; 37(11):1359-65. PubMed ID: 11435065
[TBL] [Abstract][Full Text] [Related]
18. CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer.
Masuda N; Fukuoka M; Takada M; Kusunoki Y; Negoro S; Matsui K; Kudoh S; Takifuji N; Nakagawa K; Kishimoto S
J Clin Oncol; 1992 Nov; 10(11):1775-80. PubMed ID: 1328551
[TBL] [Abstract][Full Text] [Related]
19. Clinical studies of irinotecan alone and in combination with cisplatin.
Fukuoka M; Masuda N
Cancer Chemother Pharmacol; 1994; 34 Suppl():S105-11. PubMed ID: 8070018
[TBL] [Abstract][Full Text] [Related]
20. [Irinotecan plus cisplatin for the treatment of advanced non-small cell lung cancer].
Zhang XR; Zhu YZ; Xiu QY; Han FC; Liu DQ; Chu DT
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):777-9. PubMed ID: 17366795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]